COMMUNIQUÉS West-GlobeNewswire

Major shareholder announcement
11/09/2019
Company announcement 11 September 2019 Major shareholder announcement Pursuant to section 30 of Consolidated Act no. 459 of 24 April 2019 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces [...]
Zealand Pharma completes subscription of new shares and registration of capital increase
11/09/2019
Company announcement – No. 33 / 2019 Zealand Pharma completes subscription of new shares and registration of capital increase Copenhagen, September 11, 2019 – With reference to the company announcement no. 30/2019 dated [...]
Trading in GN Store Nord shares by board members, executives and associated persons
11/09/2019
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Emerald Health Therapeutics annonce un financement de parts de débentures convertibles de 25 millions USD
11/09/2019
CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 10 sept. 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
Digirad Corporation Acquires ATRM Holdings, Inc.
10/09/2019
Transforms into a Diversified Holding Company Completes Private Placement of Preferred Stock for $3.0 Million SUWANEE, Ga., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ: DRAD) (“Digirad” or the “ [...]
Kane Biotech Releases Inaugural Business Update Video
10/09/2019
WINNIPEG, Manitoba, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Update regarding registration of new shares for Zealand Pharma
10/09/2019
Company announcement – No. 32 / 2019 Update regarding registration of new shares for Zealand Pharma Copenhagen, September 10, 2019 – In reference to Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) [...]
T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract
10/09/2019
Contract includes initial phase valued at $6 million, with a total value up to $69 million Call will also cover restructuring of CRG term loan agreement and Breakthrough Technology contract with Premier Inc. Company to [...]
Adamas Announces New Employment Inducement Grant
10/09/2019
EMERYVILLE, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted four new employees the [...]
T2 Biosystems Announces Restructuring of CRG Term Loan Agreement
10/09/2019
Extends Interest-Only Payment Period Through December 2022 and Reduces Minimum Revenue Targets LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of [...]
SeaSpine to Present at the Ladenburg Thalmann 2019 Healthcare Conference
10/09/2019
CARLSBAD, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Prevail Therapeutics Provides Program Update on PR001 in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease
10/09/2019
NEW YORK, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (NASDAQ: PRVL), a biotechnology company developing AAV-based gene therapies for patients with neurodegenerative disorders, today provided an update [...]
T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.
10/09/2019
Contract effective September 1, 2019 LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in [...]
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting
10/09/2019
THE WOODLANDS, Texas, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that clinical data for Zynquista TM (sotagliflozin) will be presented at the upcoming European [...]
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi
10/09/2019
Conference Call and Webcast Today at 5:00 pm EDT / 4:00 pm CDT THE WOODLANDS, Texas, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced the termination of its alliance with [...]
Civil rights movement intensifies as hate crimes increase in LGBTQ communities in Africa
10/09/2019
TORONTO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Recently, in Uganda, police with machine guns raided the offices of a human rights group. Pepe Julian Onziema, a director with Sexual Minorities Uganda, one of the [...]
Need a Clean Slate? How to Care for Your Skin After Tattoo Removal; American Academy of Dermatology
10/09/2019
ROSEMONT, Ill., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Tattoos used to be considered permanent, but thanks to advances in laser technology, dermatologists from the American Academy of Dermatology say today’s lasers can get [...]
Emerald Health Therapeutics Announces Closing of $25 million Convertible Debenture Unit Financing
10/09/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the " [...]
The Delta Companies’ Ty Chambers Takes On New Role as President of Client Services
10/09/2019
DALLAS, Sept. 10, 2019 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading healthcare staffing firm, announced that Ty Chambers has taken on the role of President of Client Services. As President of Client Services [...]

Pages